France · 
Who invested in PEP-Therapy?
PEP-Therapy's investors include Seventure Partners, Bpifrance, Italian Angels for Growth and Bernard Majoie.
2015201620172018201920202021
$1.4MVenture$1.9MSeries A
France · Series A startup
Who invested in PEP-Therapy
Funding summaryUpdated 26 Oct 2026
$3.3Mraised across 2 rounds since 2015, from 2 sources
$1.4MVenture$1.9MSeries A
- Latest round
- Series A, $1.9MJul 2021
- Step-upi
- 1.3×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $1.4M Apr 2015
- Biggest round
- $1.9M Series A · Jul 2021
- Between rounds
- 6.2 years from the last two
The rounds
- Jul 2021
- Apr 2015
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Italian Angels for GrowthVC firm1round
Bernard Majoieno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list PEP-Therapy as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about PEP-Therapy
How much has PEP-Therapy raised?
PEP-Therapy has raised $3.3M across 2 rounds since 2015.
When did PEP-Therapy last raise?
PEP-Therapy's most recent round was a Series A of $1.9M in Jul 2021.
What was PEP-Therapy's biggest round?
Its most recent round, $1.9M in Jul 2021, is also its largest on record.
Who backed PEP-Therapy first?
PEP-Therapy's first round on record, in Apr 2015, was backed by Seventure Partners and Bernard Majoie.
What stage is PEP-Therapy at?
PEP-Therapy's latest named round is a Series A, in Jul 2021.
Where is PEP-Therapy based?
PEP-Therapy is based in France.
Companies like PEP-Therapy
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.